Stockscreener 앱 받기
0.11%
Pfizer Inc 주식(PFE)의 최신 뉴스
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own? - Yahoo Finance
Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing? - Yahoo Finance
Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside? - Yahoo Finance
Pfizer (PFE) Balances Global Pricing Opportunity with New Revenue Sharing - Yahoo Finance
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks. - The Motley Fool
How AI Is Helping Match Patients to Clinical Trials Faster - Pfizer
Pfizer Inc Lobbyists, 2013 - OpenSecrets
Pfizer (NYSE:PFE) Back In Focus As Pricing Deal, Migraine Study, And Vaccine Milestone Shape Its Reset - Kalkine Media
Pfizer (PFE) Bets Big on RSV and Cancer Care - TipRanks
Pfizer: Buy Before The Street Catches Up To Its Own Numbers (NYSE:PFE) - Seeking Alpha
Pfizer (PFE) Targets Air Traffic Fees Over Unpaid Vaccines. Can it Turn a Court Win Into Cash? - Insider Monkey
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026? - The Motley Fool
Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money? - Yahoo Finance
Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study - TipRanks
Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - GlobeNewswire Inc.
Pfizer stock reports a Q2 earnings beat at USD 28.43 - AD HOC NEWS
Pfizer stock heads into the open after a 0.82 percent gain - AD HOC NEWS
What Could Pfizer (PFE) Unlock From Faster FDA Reviews And Orphan Drug Growth? - Yahoo Finance
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost? - Yahoo Finance
Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans (NYSE:PFE) - Seeking Alpha
Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential - TipRanks
What Is Keeping Pfizer Inc. (NYSE:PFE) in the Healthcare Spotlight This September? - Kalkine Media
Pfizer Says It Removed Affected Batches From Market Amid Karnataka Fake Drug Probe - Medical Dialogues
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick? - TradingView
Pfizer stock gains as Q1 profit rises 6.6 percent - AD HOC NEWS
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - theglobeandmail.com
Pfizer Inc. : JP Morgan is Neutral - marketscreener.com
Pfizer (NYSE:PFE) Nears Breakout as Technical Strength and Setup Quality Reach Top Marks - ChartMill
Pfizer stock heads into the open after a 0.23 percent gain - AD HOC NEWS
Pfizer stock ends the day at USD 27.94 at the close - AD HOC NEWS
PFE Stock Quote Price and Forecast - CNN
Pfizer stock trades at INR 4,025.50 after India drug crackdown - AD HOC NEWS
What Is The Best Case For Pfizer Stock? - Yahoo Finance
Eli Lilly Vs. Pfizer in 2027: One Is a Much Better Place to Park Your Pharmaceutical Capital Next Year - Yahoo Finance
Pfizer’s International Chief Just Explained How the Turnaround Actually Works. Here’s Where the Stock Could Go - TIKR.com
Why Is Pfizer (NYSE:PFE) Back in Focus as Wall Street Balances Growth and Defensive Demand? - Kalkine Media
BridgeBio says heart disease therapy Attruby beat Pfizer’s Vyndamax in real world study - Seeking Alpha
Pfizer Inc. (PFE) stock price, news, quote and history - Yahoo Finance UK
Pfizer, Kraft, and UPS All Yield More Than 6%. Which of These Dividend Stocks Is the Safest Option Today? - Yahoo Finance
Pfizer stock holds near USD 28 as new products gain ground - AD HOC NEWS
Can Pfizer (NYSE:PFE) turn pipeline renewal and commercial launches into a stronger market story? - Kalkine Media
Pfizer Inc. stock heads into the open after a 0.23 percent gain - AD HOC NEWS
What Is Keeping Pfizer (NYSE:PFE) in S&P 500 Market Focus Today? - Kalkine Media
Party General Secretary and President visits US pharmaceutical giant Pfizer - VOV.VN
Is Pfizer (PFE) Getting Too Pricey After Its 24% Rise? - simplywall.st
Pfizer: A Quietly Outperforming High-Dividend Idea, Pipeline On Watch (Upgrade) - Seeking Alpha
Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi, sources say - Reuters
Pfizer Inc. - Britannica
Pfizer stock rises 0.23 percent at the close - AD HOC NEWS
Pfizer: A Conservative Valuation Leaves Room For A Post-LOE Re-Rating (NYSE:PFE) - Seeking Alpha
Pfizer: Stagnant Dividends At Rich YieldsIncome Before Appreciation (NYSE:PFE) - Seeking Alpha
Pfizer: The Market Won't Pay For 2029 Until It CanDowngrading To Hold (NYSE:PFE) - Seeking Alpha
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts - Business Wire
Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says - marketscreener.com
What's Driving Pfizer's Move in Healthcare Stocks This Week? - Kalkine Media
Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures wi - Benzinga
Transcript : Pfizer Inc. Presents at U.S. All Stars Conference, Sep-22-2026 10:50 AM - marketscreener.com
Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline - Yahoo Finance
AbbVie vs. Pfizer: Which is the Better Dividend Investment? - Intellectia AI
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September? - Yahoo Finance
Pfizer stock holds near USD 28 as earnings date approaches - AD HOC NEWS
1.06%
1.05%
자본화:
|
볼륨(24시간):